Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ales Blinc

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Medical Biochemistry|December 25, 2018
Increased Plasma Cathepsin s at the Time of Percutaneous Transluminal Angioplasty is Associated with 6-months' Restenosis of the Femoropopliteal ArteryMojca Bozic Mijovski, Vinko Boc, Ursa Pecar Fonovic, et al.
International Angiology : a Journal of the International Union of Angiology|March 19, 2021
Do we have a unified consensus on antithrombotic management of PAD?Pavel Poredos, Pier L Antignani, Ales Blinc, et al.
International Angiology : a Journal of the International Union of Angiology|July 24, 2024
Specificities of primary and secondary prevention of lower extremity artery disease: introduction to a series of reviewsPavel Poredoš, Kosmas I Paraskevas, Dimitri P Mikhailidis, et al.
International Angiology : a Journal of the International Union of Angiology|September 20, 2024
Dyslipidemia and lower extremity arterial diseaseKosmas I Paraskevas, Pavel Poredos, Agata Stanek, et al.
International Angiology : a Journal of the International Union of Angiology|July 23, 2024
Specificities of primary and secondary prevention of lower extremity artery disease in patients with diabetes mellitusAgata Stanek, Dimitri P Mikhailidis, Kosmas I Paraskevas, et al.
Autoimmunity|August 13, 2010
Could antibodies against serum amyloid A function as physiological regulators in humans?Katja Lakota, Gerhard G Thallinger, Sasa Cucnik, et al.
Current Vascular Pharmacology|October 2, 2023
The Effect of Menopause and Menopausal Hormone Therapy on the Risk of Peripheral Artery DiseasePanagiotis Anagnostis, Dimitri P Mikhailidis, Ales Blinc, et al.
Current Vascular Pharmacology|January 29, 2024
Hyperparathyroidism and Peripheral Arterial DiseasePier Luigi Antignani, Mateja K Jezovnik, Ales Blinc, et al.
Current Vascular Pharmacology|November 14, 2023
Thyroid Disorders and Peripheral Arterial DiseaseKatica Bajuk Studen, Simona Gaberscek, Katja Zaletel, et al.
Current Vascular Pharmacology|October 2, 2023
Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the ManagementAndrej Janez, Rok Herman, Pavel Poredos, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Medical Biochemistry|December 25, 2018
Increased Plasma Cathepsin s at the Time of Percutaneous Transluminal Angioplasty is Associated with 6-months' Restenosis of the Femoropopliteal ArteryMojca Bozic Mijovski, Vinko Boc, Ursa Pecar Fonovic, et al.
International Angiology : a Journal of the International Union of Angiology|March 19, 2021
Do we have a unified consensus on antithrombotic management of PAD?Pavel Poredos, Pier L Antignani, Ales Blinc, et al.
International Angiology : a Journal of the International Union of Angiology|July 24, 2024
Specificities of primary and secondary prevention of lower extremity artery disease: introduction to a series of reviewsPavel Poredoš, Kosmas I Paraskevas, Dimitri P Mikhailidis, et al.
International Angiology : a Journal of the International Union of Angiology|September 20, 2024
Dyslipidemia and lower extremity arterial diseaseKosmas I Paraskevas, Pavel Poredos, Agata Stanek, et al.
International Angiology : a Journal of the International Union of Angiology|July 23, 2024
Specificities of primary and secondary prevention of lower extremity artery disease in patients with diabetes mellitusAgata Stanek, Dimitri P Mikhailidis, Kosmas I Paraskevas, et al.
Autoimmunity|August 13, 2010
Could antibodies against serum amyloid A function as physiological regulators in humans?Katja Lakota, Gerhard G Thallinger, Sasa Cucnik, et al.
Current Vascular Pharmacology|October 2, 2023
The Effect of Menopause and Menopausal Hormone Therapy on the Risk of Peripheral Artery DiseasePanagiotis Anagnostis, Dimitri P Mikhailidis, Ales Blinc, et al.
Current Vascular Pharmacology|January 29, 2024
Hyperparathyroidism and Peripheral Arterial DiseasePier Luigi Antignani, Mateja K Jezovnik, Ales Blinc, et al.
Current Vascular Pharmacology|November 14, 2023
Thyroid Disorders and Peripheral Arterial DiseaseKatica Bajuk Studen, Simona Gaberscek, Katja Zaletel, et al.
Current Vascular Pharmacology|October 2, 2023
Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the ManagementAndrej Janez, Rok Herman, Pavel Poredos, et al.
Pageof 4